SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (896)10/21/1997 12:10:00 PM
From: D.Right  Read Replies (1) of 2173
 
Dear Henry:

I guess with the deal out it is still not enough to keep you busy on the LGND thread. You know you missed the point on purpose or maybe you don't. I wish LGND a great great future and their stock goes to 100. However you can not compare LGND's deal with AMLN's deal. AMLN retained 50% of the product right. LGND SOLD OUT their rights of many of their advanced products. LGND may have to do this deal this way with the right reason. But a sold-out is a sold-out. LLY is the employer here and LGND is the employee, though with a pretty good salary. When you invest in a company, you may want to invest in an employee, but I would like to stick with the owner.

Good luck

D.Right

PS: Please stop using my name in your post as a way to fight Tony, post to yourself instead, OK?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News